Airtag
Date | Investors | Amount | Round |
---|---|---|---|
€4.0m | Early VC | ||
N/A | Acquisition | ||
Total Funding | $4.4m |
Related Content
Recent News about Airtag
EditIDEMIA, through its MorphoTablet 2, offers advanced biometric identification solutions designed to enhance security and efficiency in border management and mobile authentication. The MorphoTablet 2 is an Android-based touchscreen device equipped with an FBI PIV IQS1 and STQC2 certified optical fingerprint sensor, enabling seamless on-the-spot identification. It operates with the MiMs3 Mobile Access application and connects to the MorphoManager centralized platform for user database synchronization and transaction log transfer. The device supports high-speed data transfer via Wi-Fi or 3G/4G networks, ensuring mobility in all situations.
IDEMIA also provides comprehensive services to assist governments in collecting Advanced Passenger Information (API) and Passenger Name Record (PNR) data, crucial for risk assessment and security clearance. These services include legal framework support, establishment of standardized communication platforms, governance and process definition, and interface support for carriers and governments. IDEMIA's solutions can be deployed through Public-Private Partnerships using a Build-Operate-Transfer (BOT) model.
Additionally, IDEMIA offers a range of eco-friendly products and services for mobile operators, including SIM cards, packaging, and optimized shipment solutions, promoting sustainability in the telecommunications industry.
Keywords: biometric identification, border management, mobile authentication, fingerprint sensor, API PNR data, legal framework support, communication platform, governance, Public-Private Partnership, sustainability.